Skip to main content

Advertisement

SpringerLink
Log in

Rituximab in the treatment of primary bilateral adrenal lymphoma with adrenal crisis

  • CASE
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Primary adrenal lymphoma (PAL) is a rare extranodal non-Hodgkin’s lymphoma. The majority of the patients are elderly men with bilateral adrenal involvements. The optimal treatment of PAL has not been well established currently. We herein report on a patient with primary bilateral adrenal lymphoma and adrenal crisis that treated with rituximab. Our case does demonstrate that rituximab could be administered without significant toxicities, and resulted in clinical improvement with disease stabilization in this critically ill patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Kumar R et al. FDG-PET imaging in primary bilateral adrenal lymphoma: a case report and review of the literature. Clin Nucl Med 2005;30:222–30.

    Article  PubMed  Google Scholar 

  2. Fukushima A et al. Primary bilateral adrenal intravascular large B-cell lymphoma associated with adrenal failure. Intern Med 2003;42:609–14.

    PubMed  Google Scholar 

  3. Coiffier B et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346:235–42.

    Article  PubMed  CAS  Google Scholar 

  4. Pfreundschuh M et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 2006;7:379–91.

    Article  PubMed  CAS  Google Scholar 

  5. Mantzios G et al. Primary adrenal lymphoma presenting as Addison’s disease: case report and review of the literature. Ann Hematol 2004;83:460–63.

    Article  PubMed  Google Scholar 

  6. Shirao S et al. Effective combined modality therapy for a patient with primary adrenal lymphoma. Rinsho Ketsueki 2006;47:204–09.

    PubMed  Google Scholar 

  7. Padate BP, Keidan J. Enteroviral meningoencephalitis in a patient with non-Hodgkin’s lymphoma treated previously with rituximab. Clin Lab Haematol 2006;28:69–71.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology and Oncology, Department of Internal Medicine, Mackay Memorial Hospital, 92, Section 2, Chung Shan North Road, Taipei, 104, Taiwan

    Ken-Hong Lim & Ruey-Kuen Hsieh

  2. Mackay Medicine, Nursing and Management College, Taipei, Taiwan

    Ken-Hong Lim

  3. Division of Nephrology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan

    Tzeun-Yuh Chiou & Cheng-Jui Lin

Authors
  1. Ken-Hong Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tzeun-Yuh Chiou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cheng-Jui Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ruey-Kuen Hsieh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ken-Hong Lim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lim, KH., Chiou, TY., Lin, CJ. et al. Rituximab in the treatment of primary bilateral adrenal lymphoma with adrenal crisis. Med Oncol 25, 107–109 (2008). https://doi.org/10.1007/s12032-007-0051-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-007-0051-7

Keywords

Search

Navigation